Ahead of Pharma Conclave 2025, Odisha Offers Mega Incentives to Build Pharma-Med-Tech Hub
Bhubaneswar: In a major industrial push, Odisha has rolled out a comprehensive Pharma-Medical Devices Policy offering a 30% capital investment subsidy on plant and machinery, 100% stamp duty exemption on concessional industrial land, a Rs 2-per-unit power subsidy, full reimbursement of electricity duty, and wage incentives of Rs 15,000 per month for women and Rs 12,500 per month for men for five years, alongside ESI/EPF reimbursement, while announcing the Pharma Conclave 2025 on December 16 in Bhubaneswar to draw investors, an effort aimed at transforming what officials acknowledge has been a "limited presence" of pharma and med-tech manufacturing in the state.
To support this transition, the government has established the Odisha Pharmaceutical Development Cell (OPDC) to coordinate policy implementation, assist investors and develop a structured ecosystem for pharmaceutical and medical-devices manufacturing. The state is also working toward creating sector-specific SEZs and building additional industrial infrastructure dedicated to the life-sciences sector.
Momentum has begun to build, with nine pharmaceutical and biotechnology companies submitting investment intents worth ₹4,349 crore for setting up manufacturing plants, biotech units and healthcare facilities across Odisha. According to state officials, these developments are aligned with the larger Viksit Odisha 2036 roadmap that seeks to position the state as a competitive industrial and innovation-driven economy.
Investment promotion activities are being led by IPICOL (Industrial Promotion & Investment Corporation of Odisha Ltd.), which has intensified outreach to industry players, highlighting the incentives, infrastructure benefits and simplified approval processes under the new policy. The government aims to convert these investment proposals into firm commitments, strengthening Odisha’s standing as an emerging pharma-med-tech hub, reports The Hindu BusinessLine.
